These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7908570)

  • 1. Ethamsylate in the prevention of periventricular-intraventricular hemorrhage in premature infants.
    Chen JY
    J Formos Med Assoc; 1993 Oct; 92(10):889-93. PubMed ID: 7908570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ethamsylate in preventing periventricular-intraventricular hemorrhage in premature infants below 34 weeks of gestation.
    Sanghvi KP; Merchant RH; Karnik A; Kulkarni A
    Indian Pediatr; 1999 Jul; 36(7):653-8. PubMed ID: 10740301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre trial of ethamsylate for prevention of periventricular haemorrhage in very low birthweight infants.
    Benson JW; Drayton MR; Hayward C; Murphy JF; Osborne JP; Rennie JM; Schulte JF; Speidel BD; Cooke RW
    Lancet; 1986 Dec; 2(8519):1297-300. PubMed ID: 2878174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The EC randomised controlled trial of prophylactic ethamsylate for very preterm neonates: early mortality and morbidity. The EC Ethamsylate Trial Group.
    Arch Dis Child Fetal Neonatal Ed; 1994 May; 70(3):F201-5. PubMed ID: 8198414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic ethamsylate for periventricular haemorrhage.
    Cooke RW; Morgan ME
    Arch Dis Child; 1984 Jan; 59(1):82-3. PubMed ID: 6696506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of symptomatic patent ductus arteriosus with ethamsylate in babies treated with exogenous surfactant.
    Amato M; Hüppi P; Markus D
    J Perinatol; 1993; 13(1):2-7. PubMed ID: 8445442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combined antenatal corticosteroids and vitamin K therapy for preventing periventricular-intraventricular hemorrhage in premature newborns less than 35 weeks gestation.
    Liu J; Wang Q; Zhao JH; Chen YH; Qin GL
    J Trop Pediatr; 2006 Oct; 52(5):355-9. PubMed ID: 16751657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental outcome of the use of etamsylate for prevention of periventricular haemorrhage in a randomised controlled trial.
    Schulte J; Osborne J; Benson JW; Cooke R; Drayton M; Murphy J; Rennie J; Speidel B
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F31-5. PubMed ID: 15613570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etamsylate for prevention of periventricular haemorrhage.
    Hunt RW
    Arch Dis Child Fetal Neonatal Ed; 2005 Jan; 90(1):F3-5. PubMed ID: 15613569
    [No Abstract]   [Full Text] [Related]  

  • 11. [Level of vitamin K-dependent coagulation factors in premature infants and the influence of maternal antenatal administration of vitamin K1 on their activity].
    Liu J; Wang Q; Chen YH; Qin GL; Zhao JH; Zhu LC
    Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):908-10. PubMed ID: 16412352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular hemorrhage in preterm infants: coagulation perspectives.
    Kuperman AA; Kenet G; Papadakis E; Brenner B
    Semin Thromb Hemost; 2011 Oct; 37(7):730-6. PubMed ID: 22187395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic indomethacin for prevention of intraventricular hemorrhage in premature infants.
    Bandstra ES; Montalvo BM; Goldberg RN; Pacheco I; Ferrer PL; Flynn J; Gregorios JB; Bancalari E
    Pediatrics; 1988 Oct; 82(4):533-42. PubMed ID: 3174314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ethamsylate on neonatal mortality in preterm infants.
    Erdem G; Yurdakök M; Tekinalp G; Hiçsönmez G
    Turk J Pediatr; 1988; 30(2):93-7. PubMed ID: 3242186
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intra-partum ethamsylate (dicynone) administration in the prevention of cerebral hemorrhage in premature infants].
    Györe F; Keserü T; Gyuranecz M; Bognár I; Kerekes L; Simon G
    Orv Hetil; 1990 Dec; 131(50):2747-52. PubMed ID: 2267123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of indomethacin for the prevention of intraventricular brain hemorrhage in high-risk neonates.
    Al-Shawaf EM; Al-Alaiyan SA; Aqeel AY; Gamal MH
    Saudi Med J; 2000 Mar; 21(3):274-7. PubMed ID: 11533797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethamsylate in the prevention of patent ductus arteriosus.
    Rosti L; Piva D; Rosti D
    Arch Pediatr Adolesc Med; 1994 Oct; 148(10):1103-4. PubMed ID: 7921106
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants.
    Bedard MP; Shankaran S; Slovis TL; Pantoja A; Dayal B; Poland RL
    Pediatrics; 1984 Apr; 73(4):435-9. PubMed ID: 6369238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine administration of phenobarbital for the prevention of intraventricular hemorrhage in premature infants: five years' experience.
    Chen HJ; Roloff DW
    J Perinatol; 1994; 14(1):15-22. PubMed ID: 8169672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethamsylate reduces immunoreactive prostacyclin metabolite in low birthweight infants with respiratory distress syndrome.
    Rennie JM; Doyle J; Cooke RW
    Early Hum Dev; 1986 Dec; 14(3-4):239-44. PubMed ID: 3542493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.